We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BODY.WS
3826
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$94K ﹤0.01%
+31,700
New +$103K
MBT
3827
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$94K ﹤0.01%
10,135
-9
-0.1% -$80
MIN
3828
Aberdeen Intermediate Income Fund
MIN
$278M
$93K ﹤0.01%
24,876
-2,405
-9% -$8.89K
STON
3829
DELISTED
StoneMor Inc.
STON
$93K ﹤0.01%
35,372
+7,950
+29% +$18.1K
APTO
3830
DELISTED
Aptose Biosciences, Inc.
APTO
$92K ﹤0.01%
61
AUY
3831
DELISTED
Yamana Gold, Inc.
AUY
$92K ﹤0.01%
21,763
-881
-4% -$4.27K
AMGN icon
3832
CALL
Amgen
AMGN
$226B
$91K ﹤0.01%
16,400
-46,400
-74% -$11.4M
IWM icon
3833
PUT
iShares Russell 2000 ETF
IWM
$81.5B
$91K ﹤0.01%
+17,400
New +$3.91M
WTI icon
3834
W&T Offshore
WTI
$577M
$91K ﹤0.01%
+18,773
New +$72.5K
HEXO
3835
DELISTED
HEXO Corp. Common Shares
HEXO
$90K ﹤0.01%
1,106
+109
+11% +$9.5K
PFE icon
3836
CALL
Pfizer
PFE
$154B
$89K ﹤0.01%
146,200
+34,500
+31% +$1.34M
RBBN icon
3837
Ribbon Communications
RBBN
$367M
$88K ﹤0.01%
11,557
-1,723
-13% -$13.2K
TMDI
3838
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$88K ﹤0.01%
51,243
+800
+2% +$1.38K
CRESY
3839
Cresud
CRESY
$767M
$87K ﹤0.01%
15,096
+544
+4% +$3.25K
AKBA icon
3840
Akebia Therapeutics
AKBA
$234M
$85K ﹤0.01%
22,395
+224
+1% +$754
LITS
3841
Lite Strategy Inc
LITS
$29.6M
$85K ﹤0.01%
1,496
WT icon
3842
WisdomTree
WT
$3.36B
$84K ﹤0.01%
13,605
+212
+2% +$1.4K
PVLA
3843
Palvella Therapeutics
PVLA
$2.19B
$84K ﹤0.01%
275
SYRS
3844
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$84K ﹤0.01%
+1,550
New +$91.7K
HWM icon
3845
CALL
Howmet Aerospace
HWM
$113B
$83K ﹤0.01%
10,900
-400
-4% -$13.3K
TBLT
3846
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$83K ﹤0.01%
10
CELP
3847
DELISTED
Cypress Environmental Partners, L.P.
CELP
$83K ﹤0.01%
34,500
CRK icon
3848
Comstock Resources
CRK
$4.22B
$81K ﹤0.01%
+12,075
New +$69.6K
WWR icon
3849
Westwater Resources
WWR
$79.1M
$81K ﹤0.01%
17,055
+4,285
+34% +$19.3K
EXEL icon
3850
CALL
Exelixis
EXEL
$13.1B
$79K ﹤0.01%
+29,900
New +$697K

Similar funds

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.